FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 339:806-811 September 17, 1998 Number 12 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Editorial by Angell, M. Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

For many years, the Food and Drug Administration (FDA) regulated botanical dietary-supplement ingredients, in most circumstances, under the provisions for food additives of the Federal Food, Drug, and Cosmetic Act to ensure that they were safe and wholesome. Currently, dietary supplements (such as botanical products, vitamins and minerals, amino acids, and tissue extracts) are regulated under the Dietary Supplement Health and Education Act of 1994, which includes several provisions that apply only to dietary supplements and dietary ingredients of dietary supplements. Included in these provisions was the removal of the ingredients of dietary supplements from regulation as food additives and . . . [Full Text of this Article]

Case Reports

Patient 1

Patient 2

Methods

Analyses of Botanical Materials for Cardiac Glycosides

Investigation of the Source of Contamination

Results

Identification of Digitalis lanata Ehrhart

Investigation of the Source of Contamination

Discussion

Source Information

From the Clinical Research and Review Staff, Office of Special Nutritionals (N.R.S., L.A.L.), the Division of Natural Products, Office of Plant and Dairy Foods and Beverages (W.R.O., S.M.C., J.M.B.), the Division of Enforcement and Programs, Office of Field Programs (B.K.A., W.A.C.), and the Instrumentation and Biophysics Branch, Office of Scientific Analysis and Support (S.M.M.), Center for Food Safety and Applied Nutrition, Food and Drug Administration, Washington, D.C.

Address reprint requests to Dr. Love at the Office of Special Nutritionals, HFS-452, CFSAN, FDA, 200 C St., SW, Washington, DC 20204-0001.

References

Related Letters:

Problems Evaluating Contamination of Dietary Supplements
Palmer M. E., Rao R. B.
Extract | Full Text  
N Engl J Med 1999; 340:568, Feb 18, 1999. Correspondence

This article has been cited by other articles:

• Curtis, P., Gaylord, S. (2005). Safety Issues in the Interaction of Conventional, Complementary, and Alternative Health Care. Complementary Health Practice Review 10: 3-31 [Abstract]  
• Cassileth, B. R., Deng, G. (2004). Complementary and Alternative Therapies for Cancer. The Oncologist 9: 80-89 [Abstract] [Full Text]  
• Larimore, W. L, O'Mathuna, D. P (2003). Quality Assessment Programs for Dietary Supplements. The Annals of Pharmacotherapy 37: 893-898 [Abstract] [Full Text]  
• Halsted, C. H (2003). Dietary supplements and functional foods: 2 sides of a coin?. Am. J. Clin. Nutr. 77: 1001S-1007 [Abstract] [Full Text]  
• Shane-McWhorter, L., Geil, P. (2002). Interactions Between Complementary Therapies or Nutrition Supplements and Conventional Medications. Diabetes Spectr. 15: 262-266 [Abstract] [Full Text]  
• White, J. (2002). PC-SPES-A Lesson for Future Dietary Supplement Research. JNCI J Natl Cancer Inst 94: 1261-1262 [Full Text]  
• Favreau, J. T., Ryu, M. L., Braunstein, G., Orshansky, G., Park, S. S., Coody, G. L., Love, L. A., Fong, T.-L. (2002). Severe Hepatotoxicity Associated with the Dietary Supplement LipoKinetix. ANN INTERN MED 136: 590-595 [Abstract] [Full Text]  
• Hepner, D. L., Harnett, M., Segal, S., Camann, W., Bader, A. M., Tsen, L. C. (2002). Herbal Medicine Use in Parturients. Anesth. Analg. 94: 690-693 [Abstract] [Full Text]  
• Goldman, P. (2001). Herbal Medicines Today and the Roots of Modern Pharmacology. ANN INTERN MED 135: 594-600 [Abstract] [Full Text]  
• Leung, J. M., Dzankic, S., Manku, K., Yuan, S. (2001). The Prevalence and Predictors of the Use of Alternative Medicine in Presurgical Patients in Five California Hospitals. Anesth. Analg. 93: 1062-1068 [Abstract] [Full Text]  
• Ang-Lee, M. K., Moss, J., Yuan, C.-S. (2001). Herbal Medicines and Perioperative Care. JAMA 286: 208-216 [Abstract] [Full Text]  
• Harkey, M. R, Henderson, G. L, Gershwin, M E., Stern, J. S, Hackman, R. M (2001). Variability in commercial ginseng products: an analysis of 25 preparations. Am. J. Clin. Nutr. 73: 1101-1106 [Abstract] [Full Text]  
• Costello, R. B., Coates, P. (2001). In the Midst of Confusion Lies Opportunity: Fostering Quality Science in Dietary Supplement Research. J. Am. Coll. Nutr. 20: 21-25 [Abstract] [Full Text]  
• Unützer, J., Klap, R., Sturm, R., Young, A. S., Marmon, T., Shatkin, J., Wells, K. B. (2000). Mental Disorders and the Use of Alternative Medicine: Results From a National Survey. Am. J. Psychiatry 157: 1851-1857 [Abstract] [Full Text]  
• Halsted, C. H (2000). Dietary supplements and The American Journal of Clinical Nutrition1. Am. J. Clin. Nutr. 71: 399-400 [Full Text]  
• Rao, J. K., Mihaliak, K., Kroenke, K., Bradley, J., Tierney, W. M., Weinberger, M. (1999). Use of Complementary Therapies for Arthritis among Patients of Rheumatologists. ANN INTERN MED 131: 409-416 [Abstract] [Full Text]  
• Palmer, M. E., Rao, R. B. (1999). Problems Evaluating Contamination of Dietary Supplements. NEJM 340: 568-568 [Full Text]  
• Sikorsk, R. i, Peters, R. (1998). Researching Alternatives. JAMA 280: 1631-1631 [Full Text]  
• Cirigliano, M., Sun, A. (1998). Advising Patients About Herbal Therapies. JAMA 280: 1565-1566 [Full Text]  
• Angell, M., Kassirer, J. P. (1998). Alternative Medicine -- The Risks of Untested and Unregulated Remedies. NEJM 339: 839-841 [Full Text]